The Monoclonal Antibody Therapy Market is predicted to reach US$ 175.5 billion by 2030 from US$ 175.5 billion in 2021, and to grow at a CAGR of ~12.9% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Type (Human mAb, Chimeric mAb, Humanized mAb and Murine mAb), by Disease Area (Cancer, Autoimmune Diseases, Inflammatory Diseases and Infectious Diseases), by Production Type (In Vitro and In Vivo), by End-user (Hospitals, Research Clinics and Others) -
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
F. Hoffman-La Roche Ltd., Bayer AG, Novo Nordisk A/S, Thermo Fisher Scientific Inc., Regeneron Pharmaceuticals Inc., AstraZeneca plc, Sanofi SA, Abbott Laboratories, Eli Lilly & Company, Mylan N.V., GlaxoSmithKline Plc, and Merck KgaA among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Monoclonal Antibody Therapy - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Monoclonal Antibody Therapy - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Monoclonal Antibody Therapy - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Monoclonal Antibody Therapy - ANALYSIS & FORECAST, BY REGION
North America Monoclonal Antibody Therapy
1. North America Monoclonal Antibody Therapy , by Country
1. US
2. Canada
1. North America Monoclonal Antibody Therapy , by Product
2. North America Monoclonal Antibody Therapy , by Type
3. North America Monoclonal Antibody Therapy , by Gender
4. North America Monoclonal Antibody Therapy , by Sales Channel
3. Europe Monoclonal Antibody Therapy
1. Europe Monoclonal Antibody Therapy , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Monoclonal Antibody Therapy , by Product
3. Europe Monoclonal Antibody Therapy , by Type
4. Europe Monoclonal Antibody Therapy , by Gender
5. Europe Monoclonal Antibody Therapy , by Sales Channel
4. Asia Pacific Monoclonal Antibody Therapy
1. Asia Pacific Monoclonal Antibody Therapy , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Monoclonal Antibody Therapy , by product
3. Asia Pacific Monoclonal Antibody Therapy , by Type
4. Asia Pacific Monoclonal Antibody Therapy , by Gender
5. Asia Pacific Monoclonal Antibody Therapy , by Sales Channel
5. Rest of the World Monoclonal Antibody Therapy
1. Rest of the World Monoclonal Antibody Therapy , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Monoclonal Antibody Therapy , by Product
3. Rest of the World Monoclonal Antibody Therapy , by Type
4. Rest of the World Monoclonal Antibody Therapy , by Gender
5. Rest of the World Monoclonal Antibody Therapy , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 67
The Bispecific Antibody Development Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Multispecific Antibody Development Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The CD19-targeted CAR-T Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Osteoarthritis Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Custom Polyclonal Antibody Production Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...
The Custom Antibody Development and Production Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competi...
The Cell Therapy Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
The Cell and Gene Therapy Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The PPMO (Peptide-PMO Conjugates) Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Hip Pain Therapy Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...